Delivery Order SPE2DB22D3016-SPE2DB25FBJN0
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $12,604.42 to AmerisourceBergen Drug Corp for the supply of Darzalex Faspro 1,800mg-30,000 15mL, a pharmaceutical product used in cancer treatment. This competitively awarded, non-set-aside contract was executed on December 4, 2025, with an ultimate completion date of December 26, 2025. The firm fixed price delivery order will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a $35,881.26 delivery order to AmerisourceBergen Drug Corp on September 3, 2025, for the supply of Darzalex Faspro 1,800mg-30,000 (15ml units), a pharmaceutical product used in cancer treatment. This firm fixed-price delivery order, which must be completed by September 24, 2025, carries no set-aside designation and was competitively awarded. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a major pharmaceutical...
- The Defense Logistics Agency awarded a $35,881.20 delivery order to AmerisourceBergen Drug Corp on October 29, 2025, for the supply of Darzalex Faspro 1,800mg/30,000 IU 15mL pharmaceutical product. This is a firm fixed price, competitively awarded contract with an ultimate completion date of November 20, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The delivery order operates under AmerisourceBergen's larger Indefinite Delivery Contract...
- The Defense Logistics Agency awarded a delivery order valued at $17,940.63 to AmerisourceBergen Drug Corp for DARZALEX FASPRO 1,800MG-30,000 15ML pharmaceutical products. This firm fixed price delivery order, issued on August 4, 2025, with an ultimate completion date of August 25, 2025, represents a non-competitive award under the company's existing Indefinite Delivery Contract with DLA. The contract will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania, the company's...
- The Defense Logistics Agency awarded a $59,802.10 delivery order to AmerisourceBergen Drug Corp on August 20, 2025, for the supply of Darzalex FasPro 1,800mg-30,000 15ml pharmaceutical product. This competitively awarded, firm fixed-price delivery order is scheduled for completion by September 11, 2025, with performance at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract carries no set-aside designation, indicating the award was made through open...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 29, 2025, for the supply of Darzalex Faspro 1,800mg-30,000 15ml pharmaceutical product. This firm fixed-price delivery order, valued at $23,920.84, represents a non-competitive set-aside transaction and is set to conclude by September 22, 2025. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania, supporting the federal government's medical supply chain...
- The U.S. Defense Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on June 24, 2025, for the supply of DARZALEX FASPRO 1,800MG-30,000 15ML, a specialized pharmaceutical product. This competitive, non-set-aside delivery order carries a firm fixed price ceiling value of $95,683.36 with an ultimate completion date of July 16, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the work at its...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on September 10, 2025, for the supply of Darzalex Faspro 1,800mg-30,000 15ml pharmaceutical product. This firm fixed price delivery order, valued at $149,505.25, represents a competitive award with no set-aside designation and is scheduled for completion by October 1, 2025. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a delivery order valued at approximately $59.8K to AmerisourceBergen Drug Corp for the supply of Darzalex Faspro 1,800mg/30,000 15ml pharmaceutical product. This firm fixed-price, non-set-aside contract is scheduled for completion by September 5, 2025, with performance taking place at the contractor's corporate office location in Conshohocken, Pennsylvania. As a major pharmaceutical distributor and critical federal medical procurement vendor,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for pharmaceutical supplies valued at $126,044.20 with a completion date of December 31, 2025. The order, issued on December 9, 2025, is for Darzalex Faspro 1,800mg-30,000 15ml, a specialty pharmaceutical product, under a firm fixed-price arrangement. This is a non-set-aside competitive award, reflecting AmerisourceBergen's capability to meet federal procurement requirements through open competition. The work...
- SPE2DB22D3016Indefinite Delivery Contract
- SPE2DB22D3016-SPE2DB25FBJN0Delivery Order
The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a $41,861.47 delivery order on September 16, 2025, for the supply of Darzalex Faspro 1,800mg-30,000 15ml, a specialty pharmaceutical product used in cancer treatment. This is a firm fixed-price, competitively awarded contract with no set-aside designation and an ultimate completion date of October 7, 2025. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. This prime contract vehicle enables the company to supply a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally, serving customers including the Defense Health Agency and U.S. Coast Guard. AmerisourceBergen's federal contract portfolio demonstrates its established capability as a critical pharmaceutical distributor within the federal medical procurement ecosystem, delivering both specialty and conventional medications across multiple therapeutic domains to support defense and veteran healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $41.9k | 9/16/25 |